Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

India's drug regulator is cracking down on illegal sales and promotion of GLP-1 weight loss drugs. Inspections are underway across the coun...

Weight loss drug risks: The government has warned of strict regulatory action against those found using surrogate advertising to promote GL...

There is no exit load on 10% of units redeemed or switched within one year of purchase. The remaining 90% of units will incur a 1% exit loa...

The government has mandated medical devices associations to adopt a uniform marketing code similar to that for pharmaceuticals. This includ...

"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...

The government has implemented a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) to control unethical practices in the phar...

The panel includes secretary of the department of pharmaceuticals S Aparna, Union health secretary Rajesh Bhushan, and Central Board of Dir...

The IPA has submitted a report to the Department of Pharmaceuticals (DoP) and National Pharmaceutical Pricing Authority (NPPA) stating that...

On September 18, when chemicals minister DV Sadananda Gowda was asked if the government had decided to make the Uniform Code for Pharmaceut...

DoP also asked pharma associations to submit compliance report and form committees to look into action taken on the complaints. Pharma lobb...

The DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” com...

Health Minister Harsh Vardhan said that the code of conduct for doctors in their relationship with pharmaceutical and allied sector industr...

The ‘Forum of Pharmaceutical Ethical Marketing Practices’ will draw a core working group from the firms to decide the modalities of taking ...

This would lead to increased levels of transparency and accountability across the healthcare industry and remove ambiguity.

After facing flak for illegal drug trials, and unethical marketing practices, the pharma industry seems to be pulling up its socks.

The minister said there were reports in newspapers that some unethical marketing practices were being followed by certain pharma companies.